Literature DB >> 3470760

Expression of a fms-related oncogene in carcinogen-induced neoplastic epithelial cells.

C Walker, P Nettesheim, J C Barrett, T M Gilmer.   

Abstract

Following carcinogen exposure in vitro, normal rat tracheal epithelial cells are transformed in a multistage process in which the cultured cells become immortal and, ultimately, neoplastic. Five cell lines derived from tumors produced by neoplastically transformed rat tracheal epithelial cells were examined for the expression of 11 cellular oncogenes previously implicated in pulmonary or epithelial carcinogenesis. RNA homologous to fms was expressed at a level 5-19 times higher than normal tracheal epithelial cells in three of five of the tumor-derived lines. All three lines expressing high levels of fms-related RNA gave rise to invasive tumors of epithelial origin when injected into nude mice. Increased expression of the fms-related mRNA was not due to gene amplification, and no gene rearrangement was detected by Southern analyses. RNA blot analysis using a 3' v-fms probe detected a 9.5-kilobase message in the three tumor-derived lines, whereas both normal rat alveolar macrophages and the human choriocarcinoma line BeWo expressed a fms transcript of approximately 4 kilobases. We conclude from these data that the gene expressed as a 9.5-kilobase transcript in these neoplastic epithelial cells is a member of a fms-related gene family but may be distinct from the gene that encodes the macrophage colony-stimulating factor (CSF-1) receptor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3470760      PMCID: PMC304529          DOI: 10.1073/pnas.84.7.1804

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity.

Authors:  C W Rettenmier; J H Chen; M F Roussel; C J Sherr
Journal:  Science       Date:  1985-04-19       Impact factor: 47.728

2.  Expression of the c-myb oncogene in human small cell lung carcinoma.

Authors:  C A Griffin; S B Baylin
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

3.  Expression of the c-fms proto-oncogene during human monocytic differentiation.

Authors:  E Sariban; T Mitchell; D Kufe
Journal:  Nature       Date:  1985 Jul 4-10       Impact factor: 49.962

4.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.

Authors:  C J Sherr; C W Rettenmier; R Sacca; M F Roussel; A T Look; E R Stanley
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

Review 5.  Oncogenes and proto-oncogenes: how do they differ?

Authors:  T Hunter
Journal:  J Natl Cancer Inst       Date:  1984-10       Impact factor: 13.506

6.  Production of arachidonic acid metabolites by macrophages exposed in vitro to asbestos, carbonyl iron particles, or calcium ionophore.

Authors:  S Kouzan; A R Brody; P Nettesheim; T Eling
Journal:  Am Rev Respir Dis       Date:  1985-04

Review 7.  Oncogenes in human cancers and in chemically induced animal tumors.

Authors:  M Barbacid
Journal:  Prog Med Virol       Date:  1985

8.  Proto-oncogene expression during two-stage carcinogenesis in mouse skin.

Authors:  R Toftgard; D R Roop; S H Yuspa
Journal:  Carcinogenesis       Date:  1985-04       Impact factor: 4.944

9.  Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia.

Authors:  T J Gonda; D Metcalf
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

10.  Cell surface expression of v-fms-coded glycoproteins is required for transformation.

Authors:  M F Roussel; C W Rettenmier; A T Look; C J Sherr
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

View more
  3 in total

1.  Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1.

Authors:  B M Kacinski; D Carter; K Mittal; L D Yee; K A Scata; L Donofrio; S K Chambers; K I Wang; T Yang-Feng; L R Rohrschneider
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

Review 2.  In vitro analysis of multistage carcinogenesis.

Authors:  P Nettesheim; D J Fitzgerald; H Kitamura; C L Walker; T M Gilmer; J C Barrett; T E Gray
Journal:  Environ Health Perspect       Date:  1987-11       Impact factor: 9.031

3.  Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors.

Authors:  B M Kacinski; D Carter; E I Kohorn; K Mittal; R S Bloodgood; J Donahue; C A Kramer; D Fischer; R Edwards; S K Chambers
Journal:  Yale J Biol Med       Date:  1989 Jul-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.